The expected Early Use Authorization from the Food and Drug Administration of the Pfizer/BioNTech COVID-19 Vaccine, and subsequent approval from the Centers for Disease Control and Prevention, raise many questions about the effectiveness of the vaccine in helping to slow the spread and who should and can get it and when.
In this segment of TriHealth’s Health Talk Live, Local 12’s Liz Bonis is joined by TriHealth Medical Director for Infectious Disease, Stephen Blatt, MD, who shares what information is known so far and addresses topics including:
Have a question for future segments of Health Talk Live? You can share them with Liz via her Facebook page or email.